A new report by the World Health Organization (WHO) has revealed that headache disorders affect around 3.1 billion people globally, making them one of the most common and disabling neurological conditions worldwide. The report underscores that migraines, tension-type headaches, and cluster headaches collectively impose a heavy personal, social, and economic burden.
Headache disorders among top three neurological conditions
According to the Global Health Estimates 2021, migraine headaches ranked third globally for age-standardized disability-adjusted life years (DALYs), following stroke and neonatal encephalopathy. The WHO emphasized that headaches are not only painful but also significantly disabling, impacting work productivity, relationships, and mental health.
The report estimates that 40% of the global population suffers from recurrent headaches, with women affected more frequently than men — largely due to hormonal factors. Headache disorders commonly begin around age 5 and persist into late adulthood, affecting people of all backgrounds and income levels.
Types and causes of headache disorders
Headache disorders include:
- Migraine: Often accompanied by nausea, vomiting, and sensitivity to light and sound. Attacks can last from hours to several days.
- Tension-type headaches: Described as a tight band-like pressure around the head, often triggered by stress or muscle tension.
- Cluster headaches: Extremely painful attacks focused around one eye, occurring multiple times a day.
- Medication-overuse headaches (MOH): Caused by excessive use of painkillers or migraine medication.
These conditions are not only physically painful but also contribute to mental health issues such as anxiety and depression, particularly among chronic migraine patients.
Treatment challenges and barriers to care
Despite their prevalence, only a small fraction of patients receive accurate diagnosis and proper treatment. Many healthcare professionals lack sufficient training to identify and manage headache disorders effectively. In some regions, essential medications like sumatriptan for migraine treatment remain unavailable.
Furthermore, public perception plays a major role — headaches are often dismissed as minor ailments, leading many to self-treat or ignore persistent symptoms, which worsens the condition.
WHO’s global response and action plan
To address this growing health burden, the WHO has prioritized headache disorders under its Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022–2031. The initiative focuses on improving diagnosis, access to medicines, and patient education while fostering research and prevention strategies.
WHO experts recommend simple lifestyle modifications — such as staying hydrated, maintaining regular sleep, reducing alcohol consumption, and using a headache diary to track triggers — as effective, low-cost management options for many patients.
The organization continues to advocate for global awareness, improved access to affordable treatment, and the inclusion of essential headache medicines in national healthcare systems.
